[HTML] springer.comFull View

[HTML][HTML] Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou, B Aikemu, X Fan… - Biomarker …, 2023 - Springer
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …
被引用次数：24 相关文章

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy.

E Zhang, C Ding, S Li, X Zhou, B Aikemu… - Biomarker …, 2023 - search.ebscohost.com
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …
[HTML] nih.gov

[HTML][HTML] Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou, B Aikemu… - Biomarker …, 2023 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …
[HTML] biomedcentral.com

[HTML][HTML] Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou… - Biomarker …, 2023 - biomarkerres.biomedcentral.com
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, XZ Aikemu, X Fan… - Biomarker …, 2023 - search.proquest.com
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou, B Aikemu… - Biomarker …, 2023 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy.

E Zhang, C Ding, S Li, X Zhou, B Aikemu, X Fan… - Biomarker …, 2023 - europepmc.org
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy.

E Zhang, C Ding, S Li, X Zhou, B Aikemu, X Fan… - Biomarker …, 2023 - europepmc.org
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …
[PDF] biomedcentral.com

[PDF][PDF] Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou, B Aikemu, X Fan… - 2023 - biomarkerres.biomedcentral.com
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …